companydata.dkRenescience A/S: Financial statements 2022
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 10,831,000 and a net result of DKK -13,301,000 compared with DKK -8,322,000 the year before. That is an increase of 35.9% compared with the year before. The profit margin was -122.8%. Equity amounted to DKK 182,960,000. The solvency ratio was 84.2%.
- Revenue
- 10,831,000 kr.
- Gross Profit
- -10,887,000 kr.
- Profit/Loss
- -13,301,000 kr.
- Equity
- 182,960,000 kr.
- Total Assets
- 217,391,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 10.8 mio. | -10.9 mio. | -13.3 mio. | 183 mio. | 0 |
| 2021 | 8 mio. | -11.4 mio. | -8.3 mio. | 22.8 mio. | - |
| 2020 | 1.7 mio. | -16.6 mio. | -13.5 mio. | 31.1 mio. | - |
| 2019 | - | -23.2 mio. | -18.1 mio. | 44.6 mio. | - |
| 2018 | - | -24.3 mio. | -19.1 mio. | 62.7 mio. | - |
Keep an eye on Renescience A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Renescience A/S has published its annual report for 2021. Revenue came to DKK 7,970,000, and the net result was DKK -8,322,000.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.